Search research articles
Contact Us
Filters
Showing results (201-210 of 266) with videos related to
Page
of 27
Sort By:
Current Medical Research and Opinion
|
August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study
C Ballard, M Sauter, P Scheltens, et al.
Brain : a Journal of Neurology
|
May 13, 1998
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms
G J Nijeholt, M A van Walderveen, J A Castelijns, et al.
Neurology
|
March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures
W J P Henneman, J D Sluimer, J Barnes, et al.
Neuroimage
|
October 16, 2002
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry
E J Burton, G Karas, S M Paling, et al.
Neurology
|
December 19, 2009
Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment
N Tolboom, W M van der Flier, M Yaqub, et al.
Magnetic Resonance Imaging
|
January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions
J H van Waesberghe, J A Castelijns, P Scheltens, et al.
Neurology
|
October 28, 2009
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M I Kester, A E van der Vlies, M A Blankenstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 25, 2005
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease
L A van de Pol, A Hensel, W M van der Flier, et al.
Alzheimer Disease and Associated Disorders
|
December 28, 1999
Vascular dementia: the role of cerebral infarcts
D Leys, T Erkinjuntti, D W Desmond, et al.
Alzheimer Disease and Associated Disorders
|
December 28, 1999
Imaging of static brain lesions in vascular dementia: implications for clinical trials
T Erkinjuntti, J V Bowler, C S DeCarli, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 266) with videos related to
Sort By:
Page
of 27
Current Medical Research and Opinion
|
August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study
C Ballard, M Sauter, P Scheltens, et al.
Brain : a Journal of Neurology
|
May 13, 1998
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms
G J Nijeholt, M A van Walderveen, J A Castelijns, et al.
Neurology
|
March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures
W J P Henneman, J D Sluimer, J Barnes, et al.
Neuroimage
|
October 16, 2002
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry
E J Burton, G Karas, S M Paling, et al.
Neurology
|
December 19, 2009
Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment
N Tolboom, W M van der Flier, M Yaqub, et al.
Magnetic Resonance Imaging
|
January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions
J H van Waesberghe, J A Castelijns, P Scheltens, et al.
Neurology
|
October 28, 2009
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M I Kester, A E van der Vlies, M A Blankenstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 25, 2005
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease
L A van de Pol, A Hensel, W M van der Flier, et al.
Alzheimer Disease and Associated Disorders
|
December 28, 1999
Vascular dementia: the role of cerebral infarcts
D Leys, T Erkinjuntti, D W Desmond, et al.
Alzheimer Disease and Associated Disorders
|
December 28, 1999
Imaging of static brain lesions in vascular dementia: implications for clinical trials
T Erkinjuntti, J V Bowler, C S DeCarli, et al.
Page
of 27